Buchumschlag

Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors

Introduction: Alzheimer's disease (AD) has a long prodromal stage and identifying high-risk individuals is critical. We aimed to investigate the ability of A beta misfolding in blood plasma, APOE4 status, and dementia risk factors to predict diagnosis of AD. Methods: Within a community-based co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stocker, Hannah (VerfasserIn) , Nabers, Andreas (VerfasserIn) , Perna, Laura (VerfasserIn) , Möllers, Tobias (VerfasserIn) , Rujescu, Dan (VerfasserIn) , Hartmann, Annette (VerfasserIn) , Holleczek, Bernd (VerfasserIn) , Schöttker, Ben (VerfasserIn) , Gerwert, Klaus (VerfasserIn) , Brenner, Hermann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 January 2020
In: Alzheimer's and dementia
Year: 2020, Jahrgang: 16, Heft: 2, Pages: 283-291
ISSN:1552-5279
DOI:10.1016/j.jalz.2019.08.189
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jalz.2019.08.189
Volltext
Verfasserangaben:Hannah Stocker, Andreas Nabers, Laura Perna, Tobias Möllers, Dan Rujescu, Annette Hartmann, Bernd Holleczek, Ben Schöttker, Klaus Gerwert, Hermann Brenner
Beschreibung
Zusammenfassung:Introduction: Alzheimer's disease (AD) has a long prodromal stage and identifying high-risk individuals is critical. We aimed to investigate the ability of A beta misfolding in blood plasma, APOE4 status, and dementia risk factors to predict diagnosis of AD. Methods: Within a community-based cohort, A beta misfolding in plasma measured by immuno-infrared sensor and APOE genotypewere determined at baseline in 770 participants followed over 14 years. Associations between A beta misfolding, APOE4, and other predictors with clinical AD, vascular dementia, and mixed dementia diagnoses were assessed. Results: A beta misfolding was associated with a 23-fold increased odds of clinical AD diagnosis within 14 years. No association was observed with vascular dementia/mixed dementia diagnoses. APOE4-positive participants had a 2.4-fold increased odds of clinical AD diagnosis within 14 years. Discussion: A beta misfolding in blood plasma was a strong, specific risk prediction marker for clinical AD evenmany years before diagnosis in a community-based setting.
Beschreibung:Gesehen am 07.07.2020
Beschreibung:Online Resource
ISSN:1552-5279
DOI:10.1016/j.jalz.2019.08.189

Ähnliche Einträge